TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

NITRO-DUR

NITROGLYCERIN
Approved 1985-12-10
1
Indication
--
Phase 3 Trials
40
Years on Market

Details

Status
Prescription
First Approved
1985-12-10
Routes
TRANSDERMAL
Dosage Forms
FILM, EXTENDED RELEASE

Companies

Active Ingredient: NITROGLYCERIN

NITRO-DUR Approval History

Loading approval history...

What NITRO-DUR Treats

2 indications

NITRO-DUR is approved for 2 conditions since its original approval in 1985. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Angina Pectoris
  • Coronary Artery Disease
Source: FDA Label

NITRO-DUR Boxed Warning

You must consult your doctor for important information before using this drug....

Drugs Similar to NITRO-DUR

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

MONOKET
ISOSORBIDE MONONITRATE
2 shared
OMNIVIUM PHARMS
Shared indications:
Angina PectorisCoronary Artery Disease
NITROGLYCERIN
NITROGLYCERIN
2 shared
RUBICON RESEARCH
Shared indications:
Angina PectorisCoronary Artery Disease
NITROLINGUAL PUMPSPRAY
NITROGLYCERIN
2 shared
POHL BOSKAMP
Shared indications:
Angina PectorisCoronary Artery Disease
NITROMIST
NITROGLYCERIN
2 shared
EVUS
Shared indications:
Angina PectorisCoronary Artery Disease
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AMLODIPINE BESYLATE
1 shared
Viatris
Shared indications:
Coronary Artery Disease
AMLODIPINE BESYLATE AND VALSARTAN
AMLODIPINE BESYLATE
1 shared
ALEMBIC
Shared indications:
Coronary Artery Disease
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AMLODIPINE BESYLATE
1 shared
STRIDES PHARMA INTL
Shared indications:
Coronary Artery Disease
AMMONIA N 13
AMMONIA N-13
1 shared
BIOMEDCL RES FDN
Shared indications:
Coronary Artery Disease
BRILINTA
TICAGRELOR
1 shared
AstraZeneca
Shared indications:
Coronary Artery Disease
CADUET
AMLODIPINE BESYLATE
1 shared
PHARMACIA
Shared indications:
Coronary Artery Disease
CARDIOGEN-82
RUBIDIUM CHLORIDE RB-82
1 shared
BRACCO
Shared indications:
Coronary Artery Disease
CARDIOLITE
TECHNETIUM TC-99M SESTAMIBI KIT
1 shared
LANTHEUS MEDCL
Shared indications:
Coronary Artery Disease
FLYRCADO
FLURPIRIDAZ F-18
1 shared
GE HLTHCARE
Shared indications:
Coronary Artery Disease
GADAVIST
GADOBUTROL
1 shared
Bayer
Shared indications:
Coronary Artery Disease
INDERAL LA
PROPRANOLOL HYDROCHLORIDE
1 shared
ANI PHARMS
Shared indications:
Angina Pectoris
IODIXANOL
IODIXANOL
1 shared
HENGRUI PHARMA
Shared indications:
Coronary Artery Disease
KAPSPARGO SPRINKLE
METOPROLOL SUCCINATE
1 shared
SPIL
Shared indications:
Angina Pectoris
KATERZIA
AMLODIPINE BENZOATE
1 shared
AZURITY
Shared indications:
Coronary Artery Disease
MYOVIEW
TECHNETIUM TC-99M TETROFOSMIN KIT
1 shared
MEDI-PHYSICS
Shared indications:
Coronary Artery Disease
NADOLOL
NADOLOL
1 shared
Aurobindo Pharma
Shared indications:
Angina Pectoris
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

NITRO-DUR FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack.

โš ๏ธ BOXED WARNING

You must consult your doctor for important information before using this drug....

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.